About this trial
BLAAC PD is a research study to understand what Parkinson's disease looks like for Black and African American communities.
BLAAC PD is happening at research centers around the United States. The study is part of the Global Parkinson's Genetics Program (GP2). GP2 is a research project working to transform understanding of the genetics of Parkinson's disease and make that knowledge globally relevant.
Eligibility criteria
Qualifiers
Ability to provide informed consent
Age 50 years or older
Self-identify as Black or African American
Disqualifiers
Diagnosis of Parkinson's Disease and/or neurological condition
Familial history of PD and/or neurodegenerative or psychiatric conditions
Unknown family history of PD and/or neurodegenerative or psychiatric conditions
Any conditions that, in the investigator's opinion, preclude the individual's ability to carry out study activities
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Michael J. Fox Foundation for Parkinson's Research
Lead sponsor
University of Chicago
Collaborator
University of Alabama at Birmingham
Collaborator
Rush University
Collaborator
Washington University School of Medicine
Collaborator
Medical University of South Carolina
Collaborator
University Hospitals Cleveland Medical Center
Collaborator
Louisiana State University Health Sciences Center Shreveport
Collaborator
University of Florida
Collaborator
University of Maryland
Collaborator
The University of Texas Health Science Center, Houston
Collaborator
Ochsner Health System
Collaborator
Indiana University
Collaborator